Trial intelligence / Profile preview

Effect of a black seed–based combinatory medication on sexual function in women

IRCT20190527043729N1Phase 2Completed

Sponsor
Alborz University of Medical Sciences
Start
Mar 2019
Countries
1
01

Overview

Phase 2 trial of nigella sativa in female sexual dysfunction (FSD), hypoactive sexual desire disorder (HSDD), anorgasmia and 1 more, sponsored by Alborz University of Medical Sciences. Started Mar 2019; status: completed.

02

Drugs

nigella sativa
03

Conditions

female sexual dysfunction (FSD)hypoactive sexual desire disorder (HSDD)anorgasmiaSexual Arousal Disorder

Beyond the preview

Go deeper on IRCT20190527043729N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190527043729N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call